• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Cardiovasc Dis . Systemic microvascular dysfunction in COVID-19

tetano

Editor, Senior Moderator
Am J Cardiovasc Dis


. 2020 Oct 15;10(4):386-391.
eCollection 2020.
Systemic microvascular dysfunction in COVID-19


Leticia R Sabioni[SUP] 1 [/SUP], Eduardo Tibirica[SUP] 1 [/SUP], Cristiane C Lamas[SUP] 1 [/SUP], Guilherme D Amorim[SUP] 1 [/SUP], Andrea De Lorenzo[SUP] 1 [/SUP]



Affiliations

Abstract

COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while having lung injury as its most prominent feature, has been increasingly shown to affect endothelial cell function and the microvasculature. In this report, a woman with COVID-19, cardiac valve disease and spherocytosis was assessed with laser Doppler perfusion monitoring. Systemic microvascular reactivity was impaired during a worsening phase of COVID-19, but improved after clinical recovery; microcirculatory dysfunction paralleled systemic inflammation and pulmonary involvement. The assessment of systemic microcirculatory function may therefore provide insights on COVID-19 pathophysiology.

Keywords: COVID-19; cardiac valve disease; endothelial dysfunction; laser Doppler perfusion imaging; microvascular reactivity.
 
Back
Top Bottom